STOCK TITAN

MariMed Expands Access to Top-Selling Betty’s Eddies Brand in Maine

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags

MariMed (OTCQX: MRMD) has announced a new licensing agreement with The Stoned Moose to expand distribution of its Betty's Eddies™ full-spectrum fruit chews in Maine's $455 million cannabis market. The partnership will extend the brand's reach to include both adult-use and medical cannabis consumers.

Previously available only to adult-use consumers since 2022, Betty's Eddies will now be accessible to medical cannabis patients, a significant market segment that represented over half of Maine's cannabis revenues in 2024. The brand currently leads market share for edibles in Massachusetts, Maryland, and Delaware.

MariMed (OTCQX: MRMD) ha annunciato un nuovo accordo di licenza con The Stoned Moose per ampliare la distribuzione delle sue caramelle fruttate a spettro completo Betty's Eddies™ nel mercato della cannabis del Maine, del valore di 455 milioni di dollari. La partnership estenderà la presenza del marchio includendo sia i consumatori di cannabis per uso ricreativo sia quelli medici.

Disponibili finora solo per i consumatori ricreativi dal 2022, le Betty's Eddies saranno ora accessibili anche ai pazienti di cannabis medica, un segmento di mercato importante che ha rappresentato oltre la metà dei ricavi della cannabis nel Maine nel 2024. Il marchio detiene attualmente la quota di mercato maggiore per gli edibili in Massachusetts, Maryland e Delaware.

MariMed (OTCQX: MRMD) ha anunciado un nuevo acuerdo de licencia con The Stoned Moose para expandir la distribución de sus gomitas frutales de espectro completo Betty's Eddies™ en el mercado del cannabis de Maine, valorado en 455 millones de dólares. La colaboración ampliará el alcance de la marca para incluir tanto a consumidores de cannabis recreativo como medicinal.

Anteriormente disponibles solo para consumidores recreativos desde 2022, Betty's Eddies ahora estarán accesibles para pacientes de cannabis medicinal, un segmento de mercado significativo que representó más de la mitad de los ingresos del cannabis en Maine en 2024. La marca actualmente lidera la cuota de mercado de comestibles en Massachusetts, Maryland y Delaware.

MariMed (OTCQX: MRMD)The Stoned Moose와 새로운 라이선스 계약을 체결하여 메인 주의 4억 5,500만 달러 규모 대마초 시장에서 Betty's Eddies™ 풀스펙트럼 과일 젤리의 유통을 확대한다고 발표했습니다. 이번 파트너십을 통해 브랜드의 범위가 성인용 및 의료용 대마초 소비자 모두를 포함하게 됩니다.

2022년부터 성인용 소비자에게만 제공되던 Betty's Eddies가 이제는 의료용 대마초 환자들도 이용할 수 있게 되었으며, 이는 2024년 메인 주 대마초 수익의 절반 이상을 차지하는 중요한 시장 부문입니다. 이 브랜드는 현재 매사추세츠, 메릴랜드, 델라웨어에서 식용 제품 시장 점유율 1위를 차지하고 있습니다.

MariMed (OTCQX: MRMD) a annoncé un nouvel accord de licence avec The Stoned Moose pour étendre la distribution de ses bonbons fruités à spectre complet Betty's Eddies™ sur le marché du cannabis du Maine, évalué à 455 millions de dollars. Ce partenariat permettra à la marque de toucher à la fois les consommateurs de cannabis à usage récréatif et médical.

Jusqu'à présent disponibles uniquement pour les consommateurs récréatifs depuis 2022, les Betty's Eddies seront désormais accessibles aux patients utilisant du cannabis médical, un segment de marché important qui représentait plus de la moitié des revenus du cannabis dans le Maine en 2024. La marque détient actuellement la part de marché la plus importante pour les produits comestibles dans le Massachusetts, le Maryland et le Delaware.

MariMed (OTCQX: MRMD) hat eine neue Lizenzvereinbarung mit The Stoned Moose bekannt gegeben, um die Distribution seiner Betty's Eddies™ Vollspektrum-Fruchtgummis im 455 Millionen Dollar schweren Cannabismarkt von Maine auszubauen. Die Partnerschaft wird die Markenreichweite auf sowohl Freizeit- als auch medizinische Cannabisnutzer erweitern.

Bisher seit 2022 nur für Freizeitkonsumenten erhältlich, werden Betty's Eddies nun auch medizinischen Cannabispatienten zugänglich gemacht, einem wichtigen Marktsegment, das 2024 über die Hälfte der Cannabisumsätze in Maine ausmachte. Die Marke führt derzeit den Marktanteil für Esswaren in Massachusetts, Maryland und Delaware an.

Positive
  • Expansion into both adult-use and medical cannabis markets in Maine's $455M marketplace
  • Access to Maine's significant medical cannabis segment which accounts for over 50% of state cannabis revenues
  • Potential exposure to 15 million annual tourists in Maine
  • Brand already holds market leadership in edibles across multiple states
Negative
  • Financial terms of the licensing agreement not disclosed
  • Previous licensing partnership in Maine ended, suggesting potential business relationship challenges

NORWOOD, Mass., July 14, 2025 (GLOBE NEWSWIRE) -- MariMed Inc. (“MariMed,” “the Company”) (CSE: MRMD) (OTCQX: MRMD) today announced a licensing agreement with The Stoned Moose, LLC (“The Stoned Moose”), a vertically integrated cannabis operator in Maine. This partnership will significantly expand the distribution of the Company’s top-selling Betty’s Eddies™ full-spectrum fruit chews in the $455 million Maine cannabis marketplace. Terms of the deal were not disclosed.

Betty’s Eddies has been available exclusively to adult-use cannabis consumers in Maine since 2022 through a former licensing partner. The new agreement with The Stoned Moose, which owns a license that allows for both adult-use and medical cannabis distribution, will enable the state’s medical cannabis patients to purchase the brand as well. Medical cannabis sales accounted for more than half of Maine’s cannabis revenues in 2024.

“We are excited to work with The Stoned Moose to expand the availability of Betty’s Eddies to all cannabis consumers and patients in Maine, including the 15 million tourists who visit the state annually,” said Jon Levine, Chief Executive Officer of MariMed. “The brand is the market share leader for edibles in Massachusetts, Maryland, and Delaware, and we expect a similar trajectory in Maine. Strategically, this marks another important step forward in our ‘Expand the Brand’ strategy, which focuses on making our award-winning cannabis consumer products available to as many people as possible.”

ABOUT MARIMED
MariMed Inc. is a leading multi-state cannabis operator, known for developing and managing state-of-the-art cultivation, production, and retail facilities. Our award-winning portfolio of cannabis brands, including Betty's Eddies™, Bubby’s Baked™, Vibations™, InHouse™, and Nature’s Heritage™, sets us apart as an industry leader. These trusted brands, crafted with quality and innovation, are recognized and loved by consumers across the country. With a commitment to excellence, MariMed continues to drive growth and set new standards in the cannabis industry. For additional information, visit www.marimedinc.com.

ABOUT TILT
TILT helps cannabis businesses build brands. Through a portfolio of companies providing technology, hardware, cultivation and production, TILT services brands and cannabis retailers across 40 states in the U.S., as well as Canada, Israel, Mexico, South America and the European Union. TILT’s core businesses include Jupiter Research LLC, a wholly-owned subsidiary and leader in the vaporization segment focused on hardware design, research, development and manufacturing; and cannabis operations, Commonwealth Alternative Care, Inc. in Massachusetts, Standard Farms LLC in Pennsylvania, and Standard Farms Ohio, LLC in Ohio. TILT is headquartered in Phoenix, Arizona. For more information, visit www.tiltholdings.com.

IMPORTANT CAUTION REGARDING FORWARD-LOOKING STATEMENTS:

The information in this release contains “forward-looking” statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995, which are subject to several risks and uncertainties. All statements other than statements of historical facts contained in this release, including without limitation statements regarding projected financial results for 2025, including anticipated openings of dispensaries and facilities, timing of regulatory approvals, plans and objectives of management for future operations, are forward-looking statements. Without limiting the foregoing, the words “anticipates”, “believes”, “estimates”, “expects”, “expectations”, “intends”, “may”, “plans”, and other similar language, whether in the negative or affirmative, are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words.

Forward-looking statements are based on our current beliefs and assumptions regarding our business, timing of regulatory approvals, the ability to obtain new licenses, business prospects and strategic growth plan, and other future conditions.   Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict. Our actual results may differ materially from those contemplated in these forward-looking statements due to various risks, uncertainties, and other important factors, including, among others, reductions in customer spending, our ability to recruit and retain key personnel, and disruptions from the integration efforts of acquired companies.

These factors are not intended to be an all-encompassing list of risks and uncertainties that may affect our business and results of operations. These statements are not a guarantee of future performance and involve risk and uncertainties that are difficult to predict, including, among other factors, changes in demand for the Company’s services and products, changes in the law and its enforcement, and changes in the economic environment. Additional information regarding these and other factors can be found in our reports filed with the U.S. Securities and Exchange Commission. In providing these forward-looking statements, the Company expressly disclaims any obligation to update these statements publicly or otherwise, whether as a result of new information, future events or otherwise, except as required by law.

All trademarks and service marks are the property of their respective owners.

Company Contact:
Howard Schacter, Chief Communications Officer
Email: hschacter@marimedinc.com
Phone: (781) 277-0007


FAQ

What is the new licensing agreement between MariMed (MRMD) and The Stoned Moose?

MariMed has partnered with The Stoned Moose to distribute Betty's Eddies™ fruit chews in Maine's cannabis market, expanding access to both adult-use and medical cannabis consumers.

How big is the Maine cannabis market where MRMD is expanding?

The Maine cannabis marketplace is valued at $455 million, with medical cannabis sales accounting for more than half of revenues in 2024.

Where is Betty's Eddies currently the market share leader?

Betty's Eddies is currently the market share leader for edibles in Massachusetts, Maryland, and Delaware.

How many tourists visit Maine annually that could access MRMD products?

According to the press release, 15 million tourists visit Maine annually, representing a significant potential market for Betty's Eddies products.

When did Betty's Eddies first enter the Maine cannabis market?

Betty's Eddies has been available to adult-use cannabis consumers in Maine since 2022 through a former licensing partner.
Marimed

OTC:MRMD

MRMD Rankings

MRMD Latest News

MRMD Stock Data

38.98M
280.32M
14.02%
0.2%
Drug Manufacturers - Specialty & Generic
Healthcare
Link
United States
Norwood